A detailed history of Sanctuary Advisors, LLC transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Sanctuary Advisors, LLC holds 21,045 shares of INMB stock, worth $102,489. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,045
Holding current value
$102,489
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 25, 2024

BUY
$4.86 - $9.86 $102,278 - $207,503
21,045 New
21,045 $102 Million

Others Institutions Holding INMB

About Inmune Bio, Inc.


  • Ticker INMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,946,000
  • Market Cap $87.4M
  • Description
  • INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...
More about INMB
Track This Portfolio

Track Sanctuary Advisors, LLC Portfolio

Follow Sanctuary Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sanctuary Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sanctuary Advisors, LLC with notifications on news.